+1 347 708 0418
Alpha-1 Antitrypsin Deficiency Augmentation Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Alpha-1 Antitrypsin Deficiency Augmentation Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Glassia
Aralast NP
Prolastin C
Others
Segment by Application
Hospitals
Specialty Clinics
By Company
Grifols
CSL
Baxter
Kamada
Takeda
Abeona
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Glassia
1.2.3 Aralast NP
1.2.4 Prolastin C
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Perspective (2017-2028)
2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Region
2.2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Region (2017-2022)
2.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2023-2028)
2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Dynamics
2.3.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Industry Trends
2.3.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
2.3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
2.3.4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue
3.1.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue (2017-2022)
3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue
3.4 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio
3.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021
3.5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players Head office and Area Served
3.6 Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service
3.7 Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Type
4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Type (2017-2022)
4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2023-2028)
5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Application
5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Application (2017-2022)
5.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
6.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
6.2.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
6.2.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
6.2.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
6.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
6.3.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
6.3.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
6.3.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
6.4 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
6.4.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
6.4.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
7.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
7.2.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
7.2.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
7.2.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
7.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
7.3.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
7.3.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
7.3.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
7.4 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
7.4.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
7.4.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
8.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
8.2.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
8.3.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region
8.4.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
9.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
9.2.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
9.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
9.3.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
9.4 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
9.4.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
10.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
10.2.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
10.3.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
10.4.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.1.5 Grifols Recent Developments
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.2.5 CSL Recent Developments
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.3.5 Baxter Recent Developments
11.4 Kamada
11.4.1 Kamada Company Details
11.4.2 Kamada Business Overview
11.4.3 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.4.5 Kamada Recent Developments
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.5.5 Takeda Recent Developments
11.6 Abeona
11.6.1 Abeona Company Details
11.6.2 Abeona Business Overview
11.6.3 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.6.5 Abeona Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Glassia
Table 3. Key Players of Aralast NP
Table 4. Key Players of Prolastin C
Table 5. Key Players of Others
Table 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2017-2022)
Table 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2023-2028)
Table 12. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Trends
Table 13. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
Table 14. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
Table 15. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
Table 16. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Players (2017-2022)
Table 18. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2021)
Table 19. Ranking of Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service
Table 23. Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2017-2022)
Table 27. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2023-2028)
Table 29. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Application (2017-2022)
Table 31. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Application (2023-2028)
Table 33. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 63. Grifols Company Details
Table 64. Grifols Business Overview
Table 65. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 66. Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 67. Grifols Recent Developments
Table 68. CSL Company Details
Table 69. CSL Business Overview
Table 70. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 71. CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 72. CSL Recent Developments
Table 73. Baxter Company Details
Table 74. Baxter Business Overview
Table 75. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 76. Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 77. Baxter Recent Developments
Table 78. Kamada Company Details
Table 79. Kamada Business Overview
Table 80. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 81. Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 82. Kamada Recent Developments
Table 83. Takeda Company Details
Table 84. Takeda Business Overview
Table 85. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 86. Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 87. Takeda Recent Developments
Table 88. Abeona Company Details
Table 89. Abeona Business Overview
Table 90. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 91. Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 92. Abeona Recent Developments
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type: 2021 VS 2028
Figure 2. Glassia Features
Figure 3. Aralast NP Features
Figure 4. Prolastin C Features
Figure 5. Others Features
Figure 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered
Figure 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region: 2021 VS 2028
Figure 13. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players in 2021
Figure 14. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021
Figure 16. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
Figure 18. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
Figure 19. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
Figure 20. United States Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
Figure 24. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
Figure 25. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
Figure 26. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Region (2017-2028)
Figure 36. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
Figure 46. Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
Figure 52. Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 56. CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 57. Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 58. Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 59. Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 60. Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Buy
